Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

162.57
BATS BZX Real-Time Price
As of 12:36pm ET
 -0.15 / -0.09%
Today’s Change
133.64
Today|||52-Week Range
184.21
+11.19%
Year-to-Date
Verity & Verity, LLC Buys Watsco, Chevron, Exxon Mobil, Sells British American Tobacc...
11:44am / GuruFocus News - Paid Partner Content
Amgen (AMGN) Q1 Earnings Top, Sales Miss, Shares Decline
Apr 27 / Zacks.com - Paid Partner Content
Sanofi (SNY) Q1 Earnings Top, Sales Rise Y/Y, Shares Up
10:00am / Zacks.com - Paid Partner Content
Early-Morning Earnings Extravaganza
Apr 27 / TheStreet.com - Paid Partner Content
DUPONT CAPITAL MANAGEMENT Corp Buys Energy XXI Gulf Coast, Chevron, Johnson & Johnson...
Apr 27 / GuruFocus News - Paid Partner Content
Stocks Dazed After Trump NAFTA Flop, Tax Plan Disappointment; ECB Looms
Apr 27 / Investing Channel - Paid Partner Content
The 4 Principles That Drive PRIMECAP
Apr 27 / GuruFocus News - Paid Partner Content
Amgen Reports Mixed Financials Results as Its Lead Drug, Enbrel, Sees Sales Decrease
Apr 26 / TheStreet.com - Paid Partner Content
Amgen Reports 1st-Quarter Earnings Results
Apr 27 / GuruFocus News - Paid Partner Content
Amgen Reports Mixed Financials Results as Its Lead Drug, Embrel, Sees Sales Decrease
Apr 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close162.72
Today’s open162.40
Day’s range161.53 - 162.78
Volume71,637
Average volume (3 months)3,696,194
Market cap$119.7B
Dividend yield2.83%
Data as of 12:36pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+5.55%
Earnings growth (next 5 years)+6.44%
Revenue growth (last year)+6.31%
P/E ratio15.9
Price/Sales4.86
Price/Book4.02

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.19-0.28%
BIIBBiogen-4.53-1.64%
ILMNIllumina Inc+1.11+0.60%
BIVVBioverativ Inc+0.74+1.27%
Data as of 12:37pm ET, 04/28/2017

Financials

Last reporting dateApril 26, 2017
EPS forecast (this quarter)$2.99
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts